Decompression endoscopic surgery for frontal secondary headache attributed to supraorbital and supratrochlear nerve entrapment: a comprehensive review

Filipović, Boris; Ru, J. Alexander de; Langenberg, R; Borggreven, Pepijn A.; Lacković, Zdravko; Lohuis, Peter J. F. M.

doi:10.1007/s00405-017-4450-x

Cited by 10 publications

(13 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There are data to support the acceptance of invasive options based on use of frontal migraine decompression surgeries of both supratrochlear and supraorbital nerves by an endoscopic or trans palpebral approach by migraine patients. [52][53][54] Patients were willing to accept an invasive procedure for treatment of severe migraines based on medical information and other patient recommendations and advice by their peers about their experience with migraine surgery. 55 Therefore, we expect that an invasive procedure will be accepted among patient community through education when scientific data supporting the effectiveness of treatment will be available.…”

Section: Implications Of the Findingsmentioning

confidence: 99%

Intra‐arterial injection of lidocaine into middle meningeal artery to treat intractable headaches and severe migraine

Qureshi

Pfeiffer

Babar

et al. 2021

Journal of Neuroimaging

View full text Add to dashboard Cite

Background and Purpose:We report the results of intra-arterial injection of lidocaine in the middle meningeal artery in patients with intractable headache or status migrainosus. Methods:We treated four patients with intra-arterial lidocaine (2 mg/ml) in doses up to 50 mg in each middle meningeal artery via a microcatheter bilaterally (except in one patient). In two patients with intractable headache, the daily maximum intensity of headache (graded by 11-point numeric rating scale) was recorded for 7 days postprocedure. In two patients with status migrainosus, migraine-related disability 3 months prior and after treatment using MIDAS (Migraine Disability Assessment) questionnaire was recorded.Results: Intra-arterial lidocaine reduced the headache intensity from 8/10 and 10/10 to 0/10 in the two patients with intractable headaches for 2 days (day 0 and day 1) postprocedure. Despite recurrence of headache on day 2, the intensity was less than preprocedure intensity up to the last day recorded (by 3 and 2 points on day 7). In the two patients with status migrainosus, there was immediate reduction in headache intensity following intra-arterial lidocaine. The post treatment 3-month MIDAS score was lower in both patients compared with pretreatment 3-month score; 3 versus 30 and 55 versus 90.Severe disability preprocedure by MIDAS was reduced to little or no disability postprocedure in one patient.Conclusions: Intra-arterial lidocaine resulted in amelioration of headache in patients with intractable headache and those with status migrainosus with improvement lasting longer than the short half-life of lidocaine possibly related to central desensitization.

show abstract

Section: Implications Of the Findingsmentioning

confidence: 99%

Intra‐arterial injection of lidocaine into middle meningeal artery to treat intractable headaches and severe migraine

Qureshi

Pfeiffer

Babar

et al. 2021

Journal of Neuroimaging

View full text Add to dashboard Cite

show abstract

“…A screening algorithm was used to identify patients with frontal secondary headaches that have the highest chance for a successful surgical decompression. 7 The algorithm included clinical, radiological, and pharmacological elements. In total, 22 patients were included in the study after completing each part of the algorithm in a sequence ( Figure 1).…”

Section: Patient Selection and Screening Algorithmmentioning

confidence: 99%

“…Pain reduction after injection of local anesthetic, and later BoNT/A, in the corrugator muscle was regarded as evidence of a peripheral origin of headache, and importantly, a positive sign that surgery could have a successful outcome. 7 In line with that, a local anesthetic lidocaine 2%, adrenaline 1:80 000 (Xylocaine; APP Pharmaceuticals LLC) was injected in the corrugator muscle around the exit points of the STN and SON at the supraorbital rim (eFigure 1A in the Supplement). Patients with pain reduction (at least half of their initial VAS score) that started immediately after lidocaine injection and that lasted up to several hours after injection were included for further study.…”

Section: Pharmacological Elementsmentioning

confidence: 99%

Treatment of Frontal Secondary Headache Attributed to Supratrochlear and Supraorbital Nerve Entrapment With Oral Medication or Botulinum Toxin Type A vs Endoscopic Decompression Surgery

Filipović

Hakim

et al. 2018

JAMA Facial Plast Surg

Self Cite

View full text Add to dashboard Cite

IMPORTANCE Endoscopic surgical decompression of the supratrochlear nerve (STN) and supraorbital nerve (SON) is a new treatment for patients with frontal chronic headache who are refractory to standard treatment options. OBJECTIVE To evaluate and compare treatment outcomes of oral medication, botulinum toxin type A (BoNT/A) injections, and endoscopic decompression surgery in frontal secondary headache attributed to STN and supraorbital SON entrapment. DESIGN, SETTING, AND PARTICIPANTS Prospective cohort study of 22 patients from a single institution (Diakonessen Hospital Utrecht) with frontal headache of moderate-to-severe intensity (visual analog scale [VAS] score, 7-10), frontally located, experienced more than 15 days per month, and described as pressure or tension that intensifies with pressure on the area of STN and SON. A screening algorithm was used that included examination, questionnaire, computed tomography of the sinus, injections of local anesthetic, and BoNT/A in the corrugator muscle. INTERVENTIONS Different oral medication therapy for headache encountered in the study cohort, as well as BoNT/A injections (15 IU) into the corrugator muscle. Surgical procedures were performed by a single surgeon using an endoscopic surgical approach to release the supraorbital ridge periosteum and to bluntly dissect the glabellar muscle group. MAIN OUTCOMES AND MEASURES Headache VAS intensity after oral medication and BoNT/A injections. Additionally, early postoperative follow-up consisted of a daily headache questionnaire that was evaluated after 1 year. RESULTS In total, 22 patients (mean [SD] age, 42.0 [15.3] years; 7 men and 15 women) were included in this cohort study. Oral medication therapy reduced the headache intensity significantly (mean [standard error of the mean {SEM}] VAS score, 6.45 [0.20] [95% CI, 0.34-3.02; P < .001] compared with mean [SEM] pretreatment VAS score, 8.13 [0.22]). Botulinum toxin type A decreased the mean (SEM) headache intensity VAS scores significantly as well (pretreatment, 8.1 [0.22] vs posttreatment, 2.9 [0.42]; 95% CI, 3.89-6.56; P < .001). The mean (SEM) pretreatment headache intensity VAS score (8.10 [0.22]) decreased significantly after surgery at 3 months (1.30 [0.55]; 95% CI, 5.48-8.16; P < .001) and 12 months (1.09 [0.50]; 95% CI, 5.71-8.38; P < .001). There was a significant decrease of headache intensity VAS score in the surgical group over the BoNT/A group (mean [SEM] VAS score, 2.90 [0.42]) after 3 months (mean [SEM] VAS score, 1.30 [0.55]; 95% CI, 0.25-2.93; P < .001) and 12 months (mean [SEM] VAS score, 1.09 [0.50]; 95% CI, 0.48-3.16; P < .001) after surgery. CONCLUSIONS AND RELEVANCE Endoscopic decompression surgery had a long-lasting successful outcome in this type of frontal secondary headache. Even though BoNT/A had a positive effect, the effect of surgery was significantly higher. LEVEL OF EVIDENCE 3.

show abstract

“…In terms of the ICDH-3 beta classification, however, this would mean that we are discussing ‘secondary headache’ types. 44…”

Section: Introductionmentioning

confidence: 99%

Entrapment Neuropathy: A Concept for Pathogenesis and Treatment of Headaches—A Narrative Review

Filipović

Lans

et al. 2019

Clin Med Insights Ear Nose Throat

View full text Add to dashboard Cite

Entrapment neuropathy is a known cause of neurological disorders. In the head and neck area, this pathophysiological mechanism could be a trigger for headache. Over the last few decades, injection of botulinum toxin type A in the muscles that are causing the compression as well as surgical decompression have proved to be effective treatment methods worldwide for large numbers of patients with daily headaches. In particular the entrapment of the supraorbital nerves in the glabellar musculature and the occipital nerves in the neck musculature are triggers for headache disorders for which many patients are still seeking an effective treatment. This article reviews the literature and aims to bring the concept of neural entrapment to the attention of a wider audience. By doing so, we hope to give more exposure to an effective and relatively safe headache treatment.

show abstract

Decompression endoscopic surgery for frontal secondary headache attributed to supraorbital and supratrochlear nerve entrapment: a comprehensive review

Cited by 10 publications

References 44 publications

Intra‐arterial injection of lidocaine into middle meningeal artery to treat intractable headaches and severe migraine

Intra‐arterial injection of lidocaine into middle meningeal artery to treat intractable headaches and severe migraine

Treatment of Frontal Secondary Headache Attributed to Supratrochlear and Supraorbital Nerve Entrapment With Oral Medication or Botulinum Toxin Type A vs Endoscopic Decompression Surgery

Entrapment Neuropathy: A Concept for Pathogenesis and Treatment of Headaches—A Narrative Review

Contact Info

Product

Resources

About